Literature DB >> 2507746

Immunoglobulin M in the cerebrospinal fluid: an indicator of recent immunological stimulation.

M K Sharief1, E J Thompson.   

Abstract

Using a sensitive new method for detecting oligoclonal immunoglobulin M (IgM) in unconcentrated cerebrospinal fluid (CSF), the intrathecal synthesis of IgM was correlated with that of free light chains in patients with multiple sclerosis, infections of the central nervous system and other neurological conditions. A strong correlation was found between the presence of oligoclonal IgM and that of free light chains in the CSF from patients with multiple sclerosis and infections of the central nervous system. No oligoclonal IgM response was observed in patients with non-inflammatory or non-infectious neurological conditions. This implies that oligoclonal IgM has the same diagnostic significance as free light chains.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2507746      PMCID: PMC1031832          DOI: 10.1136/jnnp.52.8.949

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  20 in total

1.  Glutaraldehyde-enhanced immunofixation: a sensitive new method for detecting oligoclonal immunoglobulin M.

Authors:  M K Sharief; G Keir; E J Thompson
Journal:  J Neuroimmunol       Date:  1989-07       Impact factor: 3.478

2.  Immunoglobulin synthesis within the central nervous system in disseminated sclerosis.

Authors:  S Cohen; R Bannister
Journal:  Lancet       Date:  1967-02-08       Impact factor: 79.321

3.  Cerebrospinal fluid and serum light polypeptide chains in 160 patients with various nervous system disorders.

Authors:  O Kolar; E Anthony
Journal:  Z Neurol       Date:  1971

4.  Oligoclonal immunoglobulins, light chain ratios and free light chains in cerebrospinal fluid and serum from patients affected with various neurological diseases.

Authors:  F Bollengier; N Rabinovitch; A Lowenthal
Journal:  J Clin Chem Clin Biochem       Date:  1978-03

Review 5.  Diagnosis and classification of multiple sclerosis.

Authors:  W I McDonald; A M Halliday
Journal:  Br Med Bull       Date:  1977-01       Impact factor: 4.291

6.  Double ring formation in single radial immunodiffusion for kappa chains in multiple sclerosis cerebrospinal fluid.

Authors:  H Iwashita; F Grunwald; H Bauer
Journal:  J Neurol       Date:  1974       Impact factor: 4.849

7.  Biochemical findings in multiple sclerosis. III. Immunoglobulins of restricted heterogeneity and light chain distribution in cerebrospinal fluid of patients with multiple sclerosis.

Authors:  F Bollengier; P Delmotte; A Lowenthal
Journal:  J Neurol       Date:  1976-04-23       Impact factor: 4.849

8.  Multiple sclerosis: disturbed kappa: lambda chain ratio of immunoglobulin G in cerebrospinal fluid.

Authors:  H Link; O Zettervall
Journal:  Clin Exp Immunol       Date:  1970-03       Impact factor: 4.330

9.  Multiple sclerosis: a quantitative and qualitative study of immunoglobulin-containing cells in the central nervous system.

Authors:  M M Esiri
Journal:  Neuropathol Appl Neurobiol       Date:  1980 Jan-Feb       Impact factor: 8.090

10.  Poliomyelitis: immunoglobulin-containing cells in the central nervous system in acute and convalescent phases of the human disease.

Authors:  M M Esiri
Journal:  Clin Exp Immunol       Date:  1980-04       Impact factor: 4.330

View more
  3 in total

1.  A characteristic ganglioside antibody pattern in the CSF of patients with amyotrophic lateral sclerosis.

Authors:  A Stevens; M Weller; H Wiethölter
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-04       Impact factor: 10.154

2.  Correlation of interleukin-2 and soluble interleukin-2 receptor with clinical activity of multiple sclerosis.

Authors:  M K Sharief; E J Thompson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-02       Impact factor: 10.154

3.  Cerebrospinal Fluid Studies in Kenyan Children with Severe Falciparum Malaria.

Authors:  N Mturi; G Keir; C A Maclennan; A Ross; A C Willis; B C Elford; J A Berkley; C R J C Newton
Journal:  Open Trop Med J       Date:  2008
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.